CN87102916A - 苯并咪唑磺酰胺类及咪唑并吡啶磺酰胺类化合物、其制备及其作为药物的用途 - Google Patents

苯并咪唑磺酰胺类及咪唑并吡啶磺酰胺类化合物、其制备及其作为药物的用途 Download PDF

Info

Publication number
CN87102916A
CN87102916A CN87102916A CN87102916A CN87102916A CN 87102916 A CN87102916 A CN 87102916A CN 87102916 A CN87102916 A CN 87102916A CN 87102916 A CN87102916 A CN 87102916A CN 87102916 A CN87102916 A CN 87102916A
Authority
CN
China
Prior art keywords
represent
benzoglyoxaline
alkane
radicals
titanium dioxide
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN87102916A
Other languages
English (en)
Chinese (zh)
Inventor
约尔迪·弗里格拉·康斯坦萨
奥古斯托·科伦坡·彼诺尔
朱安·帕莱·科罗米娜斯
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Esteve Pharmaceuticals SA
Original Assignee
Laboratorios del Dr Esteve SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Laboratorios del Dr Esteve SA filed Critical Laboratorios del Dr Esteve SA
Publication of CN87102916A publication Critical patent/CN87102916A/zh
Pending legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
    • C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
    • C07D235/04—Benzimidazoles; Hydrogenated benzimidazoles
    • C07D235/24—Benzimidazoles; Hydrogenated benzimidazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2
    • C07D235/28—Sulfur atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
    • C07D513/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
    • C07D513/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
    • C07D513/12—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains three hetero rings
    • C07D513/14—Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
CN87102916A 1986-04-21 1987-04-21 苯并咪唑磺酰胺类及咪唑并吡啶磺酰胺类化合物、其制备及其作为药物的用途 Pending CN87102916A (zh)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR8605721 1986-04-21
FR8605721A FR2597478B1 (fr) 1986-04-21 1986-04-21 Benzimidazoles et imidazopyridines sulfonamides, leur preparation et leur application en tant que medicaments.

Publications (1)

Publication Number Publication Date
CN87102916A true CN87102916A (zh) 1988-04-27

Family

ID=9334440

Family Applications (1)

Application Number Title Priority Date Filing Date
CN87102916A Pending CN87102916A (zh) 1986-04-21 1987-04-21 苯并咪唑磺酰胺类及咪唑并吡啶磺酰胺类化合物、其制备及其作为药物的用途

Country Status (20)

Country Link
US (2) US4933338A (cg-RX-API-DMAC10.html)
EP (1) EP0246126A1 (cg-RX-API-DMAC10.html)
JP (1) JPH0643404B2 (cg-RX-API-DMAC10.html)
KR (1) KR930003613B1 (cg-RX-API-DMAC10.html)
CN (1) CN87102916A (cg-RX-API-DMAC10.html)
AU (1) AU608511B2 (cg-RX-API-DMAC10.html)
BR (1) BR8701897A (cg-RX-API-DMAC10.html)
CA (1) CA1300133C (cg-RX-API-DMAC10.html)
DD (1) DD297817A5 (cg-RX-API-DMAC10.html)
DK (1) DK185487A (cg-RX-API-DMAC10.html)
ES (1) ES2005158A6 (cg-RX-API-DMAC10.html)
FR (1) FR2597478B1 (cg-RX-API-DMAC10.html)
HU (1) HUT63151A (cg-RX-API-DMAC10.html)
IN (1) IN167204B (cg-RX-API-DMAC10.html)
NO (1) NO871643L (cg-RX-API-DMAC10.html)
PL (1) PL156736B1 (cg-RX-API-DMAC10.html)
PT (1) PT84724B (cg-RX-API-DMAC10.html)
RU (1) RU1813087C (cg-RX-API-DMAC10.html)
YU (1) YU46193B (cg-RX-API-DMAC10.html)
ZA (1) ZA872739B (cg-RX-API-DMAC10.html)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101497616B (zh) * 2008-01-30 2011-05-18 山东轩竹医药科技有限公司 含有氨基氧基取代的吡啶的咪唑并吡啶的化合物
CN110551145A (zh) * 2019-10-24 2019-12-10 江苏师范大学 一类呋喃并香豆素-Tr*ger’s Base衍生物及其合成方法与应用

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HU195220B (en) * 1983-05-03 1988-04-28 Byk Gulden Lomberg Chem Fqb Process for production of new fluor-alkoxi-benzimidasole-derivatives and medical compositions containig them
KR950001015B1 (ko) * 1986-01-10 1995-02-07 닛뽕 케미화 가부시끼가이샤 술폭시드 유도체의 제조방법
EP0374261A1 (en) * 1988-05-12 1990-06-27 Eisai Co., Ltd. Pyridinium salt and pharmacological composition containing the same
ZA953311B (en) 1994-04-29 1996-10-24 Lilly Co Eli Non-peptidyl tachykinin receptor antagonists
WO1999061438A1 (en) * 1998-05-23 1999-12-02 Byk Gulden Lomberg Chemische Fabrik Gmbh Quinoline-aminomethyl-pyridyl derivatives with anti-helicobacter activity
KR20010052503A (ko) 1998-06-03 2001-06-25 다니엘 피. 맥컬럼 Ｎ-헤테로사이클릭 카복실산 또는 카복실산 등입체의ｎ-결합된 설폰아미드
US6974815B2 (en) * 2002-10-11 2005-12-13 Bristol-Myers Squibb Company Hexahydro-benzimidazolone compounds useful as anti-inflammatory agents
CN121001995A (zh) * 2022-12-16 2025-11-21 腾维治疗公司 化合物、组合物和方法
CN118373826A (zh) * 2024-04-19 2024-07-23 常州大学 一种合成吲哚并1,4-二氮八元杂环类化合物的方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE502319A (cg-RX-API-DMAC10.html) * 1950-04-04
US2603649A (en) * 1950-04-04 1952-07-15 American Cyanamid Co Heterocyclic sulfonamides and method of preparing the same
GB833049A (en) * 1957-04-04 1960-04-21 Omikron Gagliardi Soc Di Fatto Improvements in the preparation of heterocyclic sulfonamides
DE2726625A1 (de) * 1976-06-25 1977-12-29 Ciba Geigy Ag Verfahren zum flammfestmachen von polyesterfasermaterialien
GB8316645D0 (en) * 1983-06-18 1983-07-20 Wyeth John & Brother Ltd Heterocyclic compounds

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101497616B (zh) * 2008-01-30 2011-05-18 山东轩竹医药科技有限公司 含有氨基氧基取代的吡啶的咪唑并吡啶的化合物
CN110551145A (zh) * 2019-10-24 2019-12-10 江苏师范大学 一类呋喃并香豆素-Tr*ger’s Base衍生物及其合成方法与应用
CN110551145B (zh) * 2019-10-24 2022-08-05 江苏师范大学 一类呋喃并香豆素-Tröger’s Base衍生物及其合成方法与应用

Also Published As

Publication number Publication date
FR2597478B1 (fr) 1988-12-16
DK185487D0 (da) 1987-04-10
BR8701897A (pt) 1988-02-02
ES2005158A6 (es) 1989-03-01
NO871643L (no) 1987-10-22
YU72387A (en) 1989-02-28
YU46193B (sh) 1993-05-28
DK185487A (da) 1987-10-22
EP0246126A1 (fr) 1987-11-19
PL265299A1 (en) 1988-07-21
JPH0643404B2 (ja) 1994-06-08
FR2597478A1 (fr) 1987-10-23
US4943570A (en) 1990-07-24
KR930003613B1 (ko) 1993-05-08
AU7143887A (en) 1987-10-22
US4933338A (en) 1990-06-12
ZA872739B (en) 1987-12-30
PT84724B (pt) 1989-12-29
KR870010050A (ko) 1987-11-30
CA1300133C (fr) 1992-05-05
RU1813087C (ru) 1993-04-30
IN167204B (cg-RX-API-DMAC10.html) 1990-09-22
PT84724A (fr) 1987-05-01
AU608511B2 (en) 1991-04-11
PL156736B1 (pl) 1992-04-30
DD297817A5 (de) 1992-01-23
JPS62289568A (ja) 1987-12-16
NO871643D0 (no) 1987-04-21
HUT63151A (en) 1993-07-28

Similar Documents

Publication Publication Date Title
CN1088702C (zh) 二取代双环杂环,其制备法及作为药物的用途
CN1031570C (zh) 吡唑并吡啶化合物的制备方法
CN1045767C (zh) 吡唑衍生物及其制法和药用组合物
CN1190434C (zh) 新的杂环化合物、其制备方法和含有它们的药物组合物及其在治疗糖尿病和相关疾病中的应用
CN1024667C (zh) 取代的氨甲基四氢化萘和取化氨甲基氢化苯并吡喃及其盐制备方法
CN1211384C (zh) 噻二唑基和噁二唑基苯基噁唑烷酮抗菌剂
CN1241916C (zh) 新的二苯脲化合物、其制备方法和含有该化合物的药物组合物
CN1038511C (zh) 咪唑并吡啶及其制备方法和制药的应用
CN86106984A (zh) 新的喹唑啉衍生物及其制备方法
CN87105680A (zh) 咪唑化合物及其制备方法，和包含该化合物的药物组合物
CN87107539A (zh) 取代的碱性2-氨基-1，2，3，4-四氢化萘
CN87100707A (zh) 含氮稠合杂环化合物，其制备方法及含有它们的药物配方
CN87101285A (zh) 8-取代的-2-氨基-1，2，3，4-四氢化荼
CN86102747A (zh) 咪唑并喹啉抗凝血酶原强心剂的制备方法
CN1500081A (zh) 乙内酰硫脲及其在治疗糖尿病方面的用途
CN1100417A (zh) N-杂芳基-n＇-苯脲衍生物及其生产和应用
CN1009831B (zh) 杂环氧代-2，3-二氮杂萘基乙酸的制备方法
CN1615299A (zh) 黄嘌呤氧化酶抑制剂
CN88101588A (zh) 制备1，4-二取代的哌嗪类化合物的方法
CN1642927A (zh) 环状酰胺
CN1738806A (zh) 氧代－氮杂双环化合物
CN1751044A (zh) 用作pepck抑制剂的磺酰胺取代的黄嘌呤
CN87102916A (zh) 苯并咪唑磺酰胺类及咪唑并吡啶磺酰胺类化合物、其制备及其作为药物的用途
CN1571781A (zh) 4－咪唑啉－2－酮化合物
CN1006382B (zh) 1，4-苯并噻嗪衍生物的制备方法

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C01 Deemed withdrawal of patent application (patent law 1993)
WD01 Invention patent application deemed withdrawn after publication